Induction of MHC class I expression by the MHC class II transactivator CIITA

被引:186
作者
Martin, BK
Chin, KC
Olsen, JC
Skinner, CA
Dey, A
Ozato, K
Ting, JPY
机构
[1] UNIV N CAROLINA,CYST FIBROSIS PULM RES & TREATMENT CTR,DEPT IMMUNOL MICROBIOL,CHAPEL HILL,NC 27599
[2] UNIV N CAROLINA,CYST FIBROSIS PULM RES & TREATMENT CTR,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599
[3] UNIV N CAROLINA,CYST FIBROSIS PULM RES & TREATMENT CTR,DEPT MED,CHAPEL HILL,NC 27599
[4] NICHHD,LAB MOL GROWTH REGULAT,NIH,BETHESDA,MD 20892
关键词
D O I
10.1016/S1074-7613(00)80347-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Major histocompatibility complex (MHC) class I-deficient cell lines were used to demonstrate that the MHC class II transactivator (CIITA) can induce surface expression of MHC class I molecules. CIITA induces the promoter of MHC class I heavy chain genes. The site alpha DNA element is the target for CIITA-induced transactivation of class I. In addition, interferon-gamma (IFN gamma)-induced MHC class I expression also requires an intact site alpha. The G3A cell line, which is defective in CIITA induction, does not induce MHC class I antigen and promoter in response to IFN gamma. Trans-dominant-negative forms of CIITA reduce class I MHC promoter function and surface antigen expression. Collectively, these data argue that CIITA has a role in class I MHC gene induction.
引用
收藏
页码:591 / 600
页数:10
相关论文
共 54 条
  • [1] AUSEBEL FM, 1987, CURRENT PROTOCOLS MO
  • [2] Burke P A, 1989, Year Immunol, V4, P23
  • [3] CLASS-II TRANSACTIVATOR REGULATES THE EXPRESSION OF MULTIPLE GENES INVOLVED IN ANTIGEN PRESENTATION
    CHANG, CH
    FLAVELL, RA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) : 765 - 767
  • [4] CLASS-II TRANSACTIVATOR (CIITA) IS SUFFICIENT FOR THE INDUCIBLE EXPRESSION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II GENES
    CHANG, CH
    FONTES, JD
    PETERLIN, M
    FLAVELL, RA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1367 - 1374
  • [5] Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression
    Chang, CH
    Guerder, S
    Hong, SC
    vanEwijk, W
    Flavell, RA
    [J]. IMMUNITY, 1996, 4 (02) : 167 - 178
  • [6] TUMOR IMMUNOGENICITY DETERMINES THE EFFECT OF B7 COSTIMULATION ON T-CELL-MEDIATED TUMOR-IMMUNITY
    CHEN, LP
    MCGOWAN, P
    ASHE, S
    JOHNSTON, J
    LI, YW
    HELLSTROM, I
    HELLSTROM, KE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) : 523 - 532
  • [7] MOLECULAR ANALYSIS OF G1B AND G3A IFN-GAMMA MUTANTS REVEALS THAT DEFECTS IN CIITA OR RFX RESULT IN DEFECTIVE CLASS-II MHC AND II-GENE INDUCTION
    CHIN, KC
    MAO, C
    SKINNER, C
    RILEY, JL
    WRIGHT, KL
    MORENO, CS
    STARK, GR
    BOSS, JM
    TING, JPY
    [J]. IMMUNITY, 1994, 1 (08) : 687 - 697
  • [8] Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: Generation of transdominant-negative mutants
    Chin, KC
    Li, GGX
    Ting, JPY
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) : 2501 - 2506
  • [9] CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259
  • [10] DIFFERENCES IN MHC AND TAP-1 EXPRESSION IN CERVICAL-CANCER LYMPH-NODE METASTASES AS COMPARED WITH THE PRIMARY TUMORS
    CROMME, FV
    VANBOMMEL, PFJ
    WALBOOMERS, JMM
    GALLEE, MPW
    STERN, PL
    KENEMANS, P
    HELMERHORST, TJM
    STUKART, MJ
    MEIJER, CJLM
    [J]. BRITISH JOURNAL OF CANCER, 1994, 69 (06) : 1176 - 1181